A novel mutation in the dry motif of the P2Y12 receptor combined with a function-reducing polymorphism in PAR1 in a patient with a bleeding disorder

被引：0
|
作者：
Austin, S. [1 ]
Patel, Y. M. [2 ]
Mitchell, M. J. [1 ]
Lordkipanidze, M. [3 ]
Lowe, G. C. [3 ]
Nisar, S. P. [4 ]
Garner, K. [4 ]
Daly, M. E. [5 ]
Watson, S. P. [3 ]
Mundell, S. J. [4 ]
机构：
[1] Guys & St Thomas Hosp NHS Fdn Trust, London, England
[2] Inst Ophthalmol, London, England
[3] Coll Med & Dent Sci, Birmingham, W Midlands, England
[4] Univ Bristol, Bristol, Avon, England
[5] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：454 / 454
页数：1
相关论文
共 36 条
  • [31] Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog
    Chhatriwala, M
    Ravi, RG
    Patel, RI
    Boyer, JL
    Jacobson, KA
    Harden, TK
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (03): : 1038 - 1043
  • [32] Identification and characterization of a novel P2Y12 variant in a patient diagnosed with type 1 von Willebrand disease in the European MCMDM-1VWD study
    Daly, Martina E.
    Dawood, Ban B.
    Lester, William A.
    Peake, Ian R.
    Rodeghiero, Francesco
    Goodeve, Anne C.
    Makris, Michael
    Wilde, Jonathan T.
    Mumford, Andrew D.
    Watson, Stephen P.
    Mundell, Stuart J.
    BLOOD, 2009, 113 (17) : 4110 - 4113
  • [33] A novel homozyous missense mutation in the P2RY12 gene results in defective ADP-mediated platelet activation in a patient suffering from a chronic bleeding disorder
    Patel, Y. M.
    McCormick, A. N.
    Mitchell, M.
    Maloney, J.
    Austin, S. K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 342 - 342
  • [34] Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function
    Jonathon P. Audia
    Xi-Ming Yang
    Edward S. Crockett
    Nicole Housley
    Ehtesham Ul Haq
    Kristen O’Donnell
    Michael V. Cohen
    James M. Downey
    Diego F. Alvarez
    Basic Research in Cardiology, 2018, 113
  • [35] Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function
    Audia, Jonathon P.
    Yang, Xi-Ming
    Crockett, Edward S.
    Housley, Nicole
    Ul Haq, Ehtesham
    O'Donnell, Kristen
    Cohen, Michael V.
    Downey, James M.
    Alvarez, Diego F.
    BASIC RESEARCH IN CARDIOLOGY, 2018, 113 (05)
  • [36] 4-((R)-2-{[6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than Clopidogrel
    Caroff, Eva
    Hubler, Francis
    Meyer, Emmanuel
    Renneberg, Dorte
    Gnerre, Carmela
    Treiber, Alexander
    Rey, Markus
    Hess, Patrick
    Steiner, Beat
    Hilpert, Kurt
    Riederer, Markus A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (23) : 9133 - 9153
1234